James Siegler to Fibrinolytic Agents
This is a "connection" page, showing publications James Siegler has written about Fibrinolytic Agents.
Connection Strength
1.717
-
Intravenous Thrombolysis Attenuates Neurologic Deterioration After Ischemic Stroke. South Med J. 2016 10; 109(10):661-667.
Score: 0.494
-
Letter by Siegler and Martin-Schild regarding article, "Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis". Stroke. 2013 Aug; 44(8):e97.
Score: 0.395
-
Endovascular vs Medical Management for Late Anterior Large Vessel Occlusion With Prestroke Disability: Analysis of CLEAR and RESCUE-Japan. Neurology. 2023 02 14; 100(7):e751-e763.
Score: 0.188
-
Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative. J Stroke Cerebrovasc Dis. 2021 Dec; 30(12):106121.
Score: 0.174
-
Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis. J Stroke Cerebrovasc Dis. 2016 Nov; 25(11):2603-2609.
Score: 0.122
-
Cryptogenic stroke: clinical consideration of a heterogeneous ischemic subtype. J Stroke Cerebrovasc Dis. 2015 May; 24(5):993-9.
Score: 0.111
-
Trimming the fat in acute ischemic stroke: an assessment of 24-h CT scans in tPA patients. Int J Stroke. 2015 Jan; 10(1):37-41.
Score: 0.105
-
Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study. Stroke. 2024 Apr; 55(4):908-918.
Score: 0.051
-
Safety Outcomes of Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions. Stroke. 2023 10; 54(10):2522-2533.
Score: 0.050
-
Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014 Apr; 23(4):e255-61.
Score: 0.026